Sleep disorders in patients with dementia in Parkinson's disease

Neuroscience and Behavioral Physiology

Volumn 43, Issue 2, 2013, Pages 223-228

  Litvinenko, I V ^a   Krasakov, I V ^a   Tikhomirova, O V ^b  

^a S M KIROV MILITARY MEDICAL ACADEMY   (Russian Federation)

^b A M Nikiforov All Russia Center for Emergency and Radiation Medicine   (Russian Federation)

Author keywords

cognitive deficits; dementia; galantamine; hallucinations; Parkinson's disease; sleep disorders

Indexed keywords

GALANTAMINE; LEVODOPA;

AGED; ARTICLE; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; CORRELATION ANALYSIS; DAYTIME SOMNOLENCE; DEMENTIA; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG DOSE INCREASE; FEMALE; HALLUCINATION; HUMAN; INTERMETHOD COMPARISON; MALE; MORNING DOSAGE; PARASOMNIA; PARKINSON DISEASE; POLYSOMNOGRAPHY; QUESTIONNAIRE; RATING SCALE; RUSSIAN FEDERATION; SLEEP DISORDER; SLEEP QUALITY; UNSPECIFIED SIDE EFFECT;

EID: 84876283379     PISSN: 00970549     EISSN: 1573899X     Source Type: Journal    
DOI: 10.1007/s11055-013-9718-z     Document Type: Article

References (51)

1. I. V. Litvinenko, A. A. Sakharovskaya, and E. V. Leonova, "Atomoxetine has positive effects on attention, gait, and daytime drowsiness in patients at the late stages of Parkinson's disease," in: Current Problems in Clinical Neurology: Proc. All-Russ. Jubilee Sci.-Appl. Conf. [in Russian], St. Petersburg (2009), p. 32.
2. I. V. Litvinenko, M. M. Odinak, V. I. Mogilnaya, and A. Yu. Emelin, "Efficacy and safety of galantamine (Reminyl) in cases of dementia in Parkinson's disease," Zh. Nevrol. Psikhiat., 110, No. 12, 21-29 (2010).
3. M. R. Nodel and N. N. Yakhno, "Mirapex (pramipexole) in the treatment of non-motor disorders in Parkinson's disease," Zh. Nevrol. Psikhiat., 108, No. 5, 32-38 (2008).
4. M. R. Nodel, "Effects of treatment with the dopamine receptor agonist Mirapex (pramipexole) on sleep disorders in Parkinson's disease," Zh. Nevrol. Psikhiat., 110, No. 3, 42-47 (2010).
5. R. L. Albin, R. A. Knoepp, R. D. Chervin, et al., "Decreased striatal dopaminergic innervation in REM sleep behavior disorder," Neurology, 55, 1410-1412 (2000).
6. International Classification of Sleep Disorders: Diagnostic and Coding Manual, American Academy of Sleep Medicine, Westchester, IL, 2nd Edition (2005).
7. K. N. Anderson, S. Jamieson, A. J. Graham, and J. M. Shneerson, "REM sleep behavior disorder treated with melatonin in a patient with Alzheimer's disease," Clin. Neurol. Neurosurg., 110, 492-495 (2008).
8. K. N. Anderson and J. M. Shneerson, "Drug treatment of REM sleep behavior disorder: the use of drug therapies other than clonazepam," J. Clin. Sleep Med., 5, 235-239 (2009).
9. R. N. Aurora, E. S. Zak, R. K. Maganti, et al., "Standards of Practice Committee; American Academy of Sleep Medicine. Best practice guide for the treatment of REM sleep behavior disorder," J. Clin. Sleep Med., 6, 1 (2010).
10. C. Baumann, "Parkinsonism with excessive daytime sleepiness - a narcolepsy-like disorder?" J. Neurol., 252, No. 2, 139-145 (2005).
11. B. F. Boeve, M. H. Silber, and T. J. Ferman, "Melatonin for treatment of REM sleep behavior disorder in neurologic disorders: results in 14 patients," Sleep Med., 4, 281-284 (2003).
12. B. F. Boeve, M. H. Silber, C. B. Caper, et al., "Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease," Brain, 130, 2770-2788 (2007).
13. K. R. Chauduri and A. H. V. Schapira, "Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment," Lancet Neurol., 8, 464-474 (2009).
14. C. Comella, "Sleep disorders in Parkinson's disease: an overview," Mov. Disord., 22, Supplement 17, 367-373 (2007).
15. Y. Compta, J. Santamaria, and L. Ratti, "Cerebrospinal hypocretin, daytime sleepiness and sleep architecture in Parkinson's disease dementia," Brain, 132, No. 2, 3308-3317 (2009).
16. J. Day, G. Damsma, and H. C. Fibiger, "Cholinergic activity in the rat hippocampus, cortex and striatum correlates with locomotor activity: an in vivo microdialysis study," Pharmacol. Biochem. Behav., 38, 723-729 (1991).
17. I. Eisensehr, R. Linke, S. Noachtar, et al., "Reduced striatal dopamine transporters in idiopathic rapid eye movement sleep behavior disorder: comparison with Parkinson's disease and controls," Brain, 123, 1155-1160 (2000).
18. J. H. Friedman and R. P. Millman, "Sleep disturbances and Parkinson's disease," CNS Spectr., 13, No. 3, Suppl. 4, 12-17 (2008).
19. J. B. Grace, M. P. Walker, and I. McKeith, "A comparison of sleep profiles in patients with dementia with Lewy bodies and Alzheimer's disease," Int. J. Geriatr. Psychiatry, 15, 1028-1033 (2000).
20. M. G. Hickey, B. M. Demaerschalk, R. J. Caselli, et al., "'Idiopathic' rapid-eye-movement (REM) sleep behavior disorder is associated with future development of neurodegenerative diseases," Neurologist, 13, No. 2, 98-101 (2007).
21. D Hobson, "Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease: a survey by the Canadian Movement Disorders Group," JAMA, 28, No. 4, 455-463 (2002).
22. A. Iranzo, J. L. Moninuevo, J. Santamaria, et al., "Rapid-eye movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study," Lancet Neurol., 5, 572-577 (2006).
23. D. Kunz and F. Bes, "Melatonin as a therapy in REM sleep behavior disorder patients: an open-labeled pilot study on the possible influence of melatonin on REM-sleep regulation," Mov. Disord., 14, 507-511 (1999).
24. O. Lapierre and J. Montplaisir, "Polysomnographic features of REM sleep behavior disorder: Development of a scoring method," Neurology, 42, 1371-1374 (1992).
25. I. Litvinenko, D. Ognev, and A. Sakharovskaya, "Atomoxetine improves sleepiness, attention and gait in advanced Parkinson's disease," Eur. J. Neurol., 16, Suppl. 3, 2600 (2009).
26. L. E. Maclean, C. C. Collins, and E. J. Byrne, "Dementia with Lewy bodies treated with rivastigmine: Effects on cognition, neuropsychiatric symptoms, and sleep," Int. Psychogeriat., 13, 277-288 (2001).
27. M. W. Mahowald and C. H. Schenk, "REM sleep insomnias," in: Principles and Practice of Sleep Medicine, M. H. Kryger, T. Roth, and W. C. Dement (eds.), Elsevier Saunders, Philadelphia, 4th edition (2005), pp. 897-916.
28. M. H. Marion, M. Qaurashi, G. Marshall, and O. Foster, "Is REM sleep behaviour disorder (RBD) a risk factor of dementia in idiopathic Parkinson's disease?" J. Neurol., 255, No. 2, 192-196 (2008).
29. G. Massironi, S. Galluzzi, and G. B. Frisoni, "Drug treatment of REM sleep behavior disorders in dementia with Lewy bodies," Int. Psychogeriatr., 15, 377-383 (2003).
30. W. A. Moraes, D. R. Poyares, C. Guilleminault, et al., "The effect of donepezil on sleep and rem sleep EEG in patients with Alzheimer disease: A double-blind placebo-controlled study," Sleep, 29, 199-205 (2006).
31. A. R. Morrison, G. L. Mann, and J. C. Hendricks, "The relationship of excessive exploratory behavior in wakefulness to paradoxical sleep without atonia," Sleep, 4, 247-257 (1981).
32. H. Niederhofer, "Donepezil in the treatment of narcolepsy," J. Clin. Sleep Med., 2, No. 1, 71-72 (2006).
33. E. J. Olson, B. F. Boeve, and M. H. Silber, "Rapid eye movement sleep behaviour disorder: demographic, clinical and laboratory findings in 93 cases," Brain, 123, 331-339 (2000).
34. J. M. Parish, "Violent dreaming and antidepressant drugs: or how paroxetine made me dream that I was fighting Saddam Hussein," J. Clin. Sleep Med., 3, 529-531 (2007).
35. R. B. Postuma, J. F. Gagnon, M. Vendette, et al., "Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder," Neurology, 72, No. 15, 1296-1300 (2009).
36. D. B. Rye, "Contribution of the pedunculopontine region to normal and altered REM sleep," Sleep, 20, 757-788 (1997).
37. C. H. Schenck, S. R. Bundlie, M. G. Ettinger, and M. W. Mahowald, "Chronic behaving disorders of human REM sleep: a new category of parasomnia," Sleep, 9, 293-308 (1986).
38. C. H. Schenck and M. W. Mahowald, "A polysomnographic, neurologic, psychiatric, and clinical outcome report on 70 consecutive cases with REM sleep behavior disorder (RBD): sustained clonazepam efficacy in 89.5% of 57 treated patients," Clev. Clin. J. Med., 57, Supplement, 9-23 (1990).
39. C. H. Schenck, M. W. Mahowald, S. W. Kim, et al., "Prominent eye movements during nrem sleep and rem sleep behavior disorder associated with fluoxetine treatment of depression and obsessive-compulsive disorder," Sleep, 15, 226-235 (1992).
40. C. H. Schenck, S. R. Bundlie, M. W. Mahowald, "Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder," Neurology, 46, 388-393 (1996).
41. C. H. Schenck and M. W. Mahowald, "Long-term, nightly benzodiazepine treatment of injurious parasomnias and other disorders of disrupted nocturnal sleep in 170 adults," Am. J. Med., 100, 333-337 (1996).
42. C. H. Schenck, S. R. Bundlie, and M. W. Mahowald, "REM behavior disorder (RBD): delayed emergence of Parkinsonism and/or dementia in 65% of older men initially diagnosed with idiopathic RBD, and an analysis of the minimum and maximum tonic and/or phasic electromyographic abnormalities found during REM sleep," Sleep, 26, Abstract supplement, 316 (2003).
43. A. Schuld, T. Kraus, M. Haack, et al., "Obstructive sleep apnea syndrome induced by clonazepam in a narcoleptic patient with REMsleep-behavior disorder," J. Sleep Res., 8, No. 4, 321-322 (1999).
44. S. Schutte and K. Doghramji, "REM behavior disorder seen with venlafaxine (Efexor)," Sleep Res., 25, 364 (1996).
45. N. Takeuchi, N. Uchimura,Y. Hashizume, et al., "Melatonin therapy for REM sleep behavior disorder," Psychiat. Clin. Neurosci., 55, 267-269 (2001).
46. M. Uchiyama, K. Isse, K. Tanaka, et al., "Incidental Lewy body disease in a patient with REM sleep behavior disorder," Neurology, 45, 709-712 (1995).
47. M. Vendette, J. F. Gagnon, A. Décary, et al., "REM sleep behavior disorder predicts cognitive impairment in Parkinson disease without dementia," Neurology, 69, No. 19, 1843-1849 (2007).
48. D. Weintraub, S. Mavandadi, and E. Mamikonyan, "Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson disease," Neurology, 75, No. 5, 448-455, (2010).
49. Y. K. Wing, S. P. Lam, S. X. Li, et al., "REM sleep behaviour disorder in Hong Kong Chinese: clinical outcome and gender comparison," J. Neurol. Neurosurg. Psychiatry, 79, No. 12, 1415-1416 (2008).
50. J. W. Winkelman and L. James, "Serotonergic antidepressants are associated with REM sleep without atonia," Sleep, 27, 317-321 (2004).
51. L. Zahodne and H. Fernandez, "Pathophysiology and treatment of psychosis in Parkinson's disease: a review," Drugs Aging, 25, No. 8, 665-682 (2008).